BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 005958
(667 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 39/184 (21%), Positives = 73/184 (39%), Gaps = 29/184 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS------------ 290
G+ Y+HS + H +L+ N+ ++ + +K+G G A +
Sbjct: 171 GLKYMHSAQVIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
Query: 291 -SPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDP------------LIFTKFKSFLTK 337
+P+ + + A D+ VG + +M+ R + P ++ + +
Sbjct: 230 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 289
Query: 338 GIDPSCLREFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRH 397
+ +R ++ + R T + DR +LL +L +PS RIS ALRH
Sbjct: 290 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQ---ALSLLGRMLRFEPSARISAAAALRH 346
Query: 398 PFLC 401
PFL
Sbjct: 347 PFLA 350
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 39/184 (21%), Positives = 73/184 (39%), Gaps = 29/184 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS------------ 290
G+ Y+HS + H +L+ N+ ++ + +K+G G A +
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVNE-NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
Query: 291 -SPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDP------------LIFTKFKSFLTK 337
+P+ + + A D+ VG + +M+ R + P ++ + +
Sbjct: 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288
Query: 338 GIDPSCLREFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRH 397
+ +R ++ + R T + DR +LL +L +PS RIS ALRH
Sbjct: 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQ---ALSLLGRMLRFEPSARISAAAALRH 345
Query: 398 PFLC 401
PFL
Sbjct: 346 PFLA 349
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 37.7 bits (86), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ EN+ I+ + IK+ G A F P + +
Sbjct: 117 GLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 173
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 289
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 37.4 bits (85), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ EN+ I+ + IK+ G A F P + +
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 288
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 37.4 bits (85), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 25/107 (23%)
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFLLQVLN 353
SN D + F + + K+ +R+ IFTK+K+ L K +N
Sbjct: 251 SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK--------------IN 296
Query: 354 RNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ +LD+ LL P+KRIS DAL+HPF+
Sbjct: 297 PKADCNEEALDLLDK-----------LLQFNPNKRISANDALKHPFV 332
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 37.4 bits (85), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ EN+ I+ + IK+ G A F P + +
Sbjct: 118 GLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 290
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 37.4 bits (85), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ EN+ I+ + IK+ G A F P + +
Sbjct: 116 GLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 288
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 37.4 bits (85), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ EN+ I+ + IK+ G A F P + +
Sbjct: 115 GLAFCHSHRVLHRDLKPENLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 37.0 bits (84), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 241 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 294
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 37.0 bits (84), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 37.0 bits (84), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+++ HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 115 GLSFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 36.6 bits (83), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 38/194 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
GV + H H + H +L+ +N+ I+ D +K+ G A F P S +
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINS-DGALKLADFGLARAF--GIPVRSYTHEVVTLWYRA 187
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLI-----FTKFKSFL--------TKG 338
PD M ++ + D+ +G + A+M+ + + P + K S L +
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 339 IDPSCLREFLLQVLNRNS-SSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRH 397
+ ++ QV + SS GF G +LLS +L P+KRIS DA+ H
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGF------CQEGIDLLSNMLCFDPNKRISARDAMNH 301
Query: 398 PFLCGPRWRVDPSI 411
P+ +DP I
Sbjct: 302 PYFKD----LDPQI 311
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 36.6 bits (83), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 38/194 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
GV + H H + H +L+ +N+ I+ D +K+ G A F P S +
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINS-DGALKLADFGLARAF--GIPVRSYTHEVVTLWYRA 187
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLI-----FTKFKSFL--------TKG 338
PD M ++ + D+ +G + A+M+ + + P + K S L +
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 339 IDPSCLREFLLQVLNRNS-SSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRH 397
+ ++ QV + SS GF G +LLS +L P+KRIS DA+ H
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGF------CQEGIDLLSNMLCFDPNKRISARDAMNH 301
Query: 398 PFLCGPRWRVDPSI 411
P+ +DP I
Sbjct: 302 PYFKD----LDPQI 311
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 36.6 bits (83), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 45/175 (25%), Positives = 65/175 (37%), Gaps = 44/175 (25%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNAADFYEDGPNNSSPDSNMDRRQ 300
G YLH H + H +L+ EN+ + R IK+ G +A F G M R
Sbjct: 133 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--------KMKER- 183
Query: 301 MMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFLLQVLNRNSSSGN 360
+ +A VLR K + K SC + + G
Sbjct: 184 -------LGTAYYIAPEVLR-----------KKYDEKCDVWSCGVILYILLCGYPPFGGQ 225
Query: 361 TGFQILDR-----------NW----GAGWNLLSLLLATKPSKRISCLDALRHPFL 400
T +IL R +W L+ L+L +PSKRIS +AL HP++
Sbjct: 226 TDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 36.2 bits (82), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 290
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 36.2 bits (82), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 122 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 241 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 294
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 36.2 bits (82), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 290
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 36.2 bits (82), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 286
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 36.2 bits (82), Expect = 0.060, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 235 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 288
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 36.2 bits (82), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 290
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 36.2 bits (82), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 286
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 36.2 bits (82), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 290
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 36.2 bits (82), Expect = 0.063, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 173
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 289
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 36.2 bits (82), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 36.2 bits (82), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 173
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 289
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 36.2 bits (82), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 36.2 bits (82), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 237
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 238 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 291
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 36.2 bits (82), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 36.2 bits (82), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 119 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 175
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 235
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 236 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 291
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 36.2 bits (82), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 288
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 35.8 bits (81), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 35.8 bits (81), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 35.8 bits (81), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 116 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 288
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 35.8 bits (81), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 286
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 35.8 bits (81), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 170
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 286
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 35.8 bits (81), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 35.8 bits (81), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 23/177 (12%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
G+ + HSH + H +L+ +N+ I+ + IK+ G A F + +P+
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFLLQ 350
+ + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 351 VLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 286
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 35.8 bits (81), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 115 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 287
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 35.8 bits (81), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 170
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 286
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 35.8 bits (81), Expect = 0.076, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 117 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 173
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 234 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 289
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 35.8 bits (81), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ + HSH + H +L+ +N+ I+ + IK+ G A F P + +
Sbjct: 118 GLAFCHSHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLREFL 348
P+ + + A D+ +G + A+MV R + D I F+ F T G + +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 349 LQVLNRNSSSGNTGFQ-------ILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
+ + S Q LD + G +LLS +L P+KRIS AL HPF
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPPLDED---GRSLLSQMLHYDPNKRISAKAALAHPFF 290
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 35.8 bits (81), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 43/213 (20%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDR-----HIKVGILGNAADFYEDG---------PN 288
GVNYLH+ +AH +L+ EN+ + +D+ HIK+ G A + EDG P
Sbjct: 127 GVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 289 NSSPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFL 348
+P+ ++ + + DM +G + L G P
Sbjct: 184 FVAPEI-VNYEPLGLEADMWSIGVITY------------------ILLSGASPFLGDTKQ 224
Query: 349 LQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFLCGPRWRVD 408
+ N S S + + + + LL + KR++ +ALRHP++ VD
Sbjct: 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP----VD 280
Query: 409 PSIDMIRWGLGSSAVRITEEYIYRQPQRARLAY 441
M+R + ++Y+ R R++LA+
Sbjct: 281 NQQAMVRRESVVNLENFRKQYVRR---RSKLAF 310
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 35.8 bits (81), Expect = 0.090, Method: Compositional matrix adjust.
Identities = 45/175 (25%), Positives = 65/175 (37%), Gaps = 44/175 (25%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNAADFYEDGPNNSSPDSNMDRRQ 300
G YLH H + H +L+ EN+ + R IK+ G +A F G M R
Sbjct: 116 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--------KMKER- 166
Query: 301 MMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFLLQVLNRNSSSGN 360
+ +A VLR K + K SC + + G
Sbjct: 167 -------LGTAYYIAPEVLR-----------KKYDEKCDVWSCGVILYILLCGYPPFGGQ 208
Query: 361 TGFQILDR-----------NW----GAGWNLLSLLLATKPSKRISCLDALRHPFL 400
T +IL R +W L+ L+L +PSKRIS +AL HP++
Sbjct: 209 TDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 35.4 bits (80), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 43/213 (20%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDR-----HIKVGILGNAADFYEDG---------PN 288
GVNYLH+ +AH +L+ EN+ + +D+ HIK+ G A + EDG P
Sbjct: 127 GVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 289 NSSPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFL 348
+P+ ++ + + DM +G + L G P
Sbjct: 184 FVAPEI-VNYEPLGLEADMWSIGVITY------------------ILLSGASPFLGDTKQ 224
Query: 349 LQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFLCGPRWRVD 408
+ N + S + + + + + LL + KR++ +ALRHP++ VD
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP----VD 280
Query: 409 PSIDMIRWGLGSSAVRITEEYIYRQPQRARLAY 441
M+R + ++Y+ R R++LA+
Sbjct: 281 NQQAMVRRESVVNLENFRKQYVRR---RSKLAF 310
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 34.7 bits (78), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 32/172 (18%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++YLH+ G+ H +++ +++ ++ D IK+ G A ++ P +P+
Sbjct: 153 ALSYLHNQGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE 211
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFLLQVLN 353
+ R D+ +G M+ +M+ E P E LQ +
Sbjct: 212 V-ISRLPYGTEVDIWSLGIMVIEMIDGE-------------------PPYFNEPPLQAMR 251
Query: 354 RNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPF--LCGP 403
R S + L + L L+L +PS+R + + L HPF L GP
Sbjct: 252 RIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLKLAGP 303
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 34.3 bits (77), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 296 DLLSKMLVIDPAKRISVDDALQHPYI 321
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 34.3 bits (77), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 296 DLLSKMLVIDPAKRISVDDALQHPYI 321
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 34.3 bits (77), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 296 DLLSKMLVIDPAKRISVDDALQHPYI 321
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 34.3 bits (77), Expect = 0.25, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 289 DLLSKMLVIDPAKRISVDDALQHPYI 314
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 34.3 bits (77), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 296 DLLSKMLVIDPAKRISVDDALQHPYI 321
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 33.9 bits (76), Expect = 0.28, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 334 DLLSKMLVIDPAKRISVDDALQHPYI 359
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 297 DLLSKMLVIDPAKRISVDDALQHPYI 322
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 334 DLLSKMLVIDPAKRISVDDALQHPYI 359
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 296 DLLSKMLVIDPAKRISVDDALQHPYI 321
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 290 DLLSKMLVIDPAKRISVDDALQHPYI 315
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 33.9 bits (76), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 40/187 (21%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDR-----HIKVGILGNAADFYEDG---------PN 288
GVNYLH+ +AH +L+ EN+ + +D+ HIK+ G A + EDG P
Sbjct: 127 GVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 289 NSSPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFL 348
+P+ ++ + + DM +G + L G P
Sbjct: 184 FVAPEI-VNYEPLGLEADMWSIGVITY------------------ILLSGASPFLGDTKQ 224
Query: 349 LQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFLCGPRWRVD 408
+ N S S + + + + LL + KR++ +ALRHP++ VD
Sbjct: 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP----VD 280
Query: 409 PSIDMIR 415
M+R
Sbjct: 281 NQQAMVR 287
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 12/27 (44%), Positives = 21/27 (77%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFLC 401
NL++ +L P+KRI+ +AL+HP++C
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPWVC 265
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 296 DLLSKMLVIDPAKRISVDDALQHPYI 321
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 297 DLLSKMLVIDPAKRISVDDALQHPYI 322
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 36/190 (18%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSP---DSNMDRR 299
V LH + H +L+ N+ I+ + +KV G A E +NS P S M
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 300 ---------QMMI-------AFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGI---- 339
++M+ A D+ G ++A++ LR + P + + L GI
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 340 ----DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRIS 390
D C+ RE++ + ++ F R G +LL +L P+KRI+
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP---RVNPKGIDLLQRMLVFDPAKRIT 299
Query: 391 CLDALRHPFL 400
+AL HP+L
Sbjct: 300 AKEALEHPYL 309
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 290 DLLSKMLVIDPAKRISVDDALQHPYI 315
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 33.9 bits (76), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 289 DLLSKMLVIDPAKRISVDDALQHPYI 314
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 33.9 bits (76), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P+KRIS DAL+HP++
Sbjct: 295 DLLSKMLVIDPAKRISVDDALQHPYI 320
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 33.9 bits (76), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 40/187 (21%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDR-----HIKVGILGNAADFYEDG---------PN 288
GVNYLH+ +AH +L+ EN+ + +D+ HIK+ G A + EDG P
Sbjct: 127 GVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 289 NSSPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFL 348
+P+ ++ + + DM +G + L G P
Sbjct: 184 FVAPEI-VNYEPLGLEADMWSIGVITY------------------ILLSGASPFLGDTKQ 224
Query: 349 LQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFLCGPRWRVD 408
+ N S S + + + + LL + KR++ +ALRHP++ VD
Sbjct: 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP----VD 280
Query: 409 PSIDMIR 415
M+R
Sbjct: 281 NQQAMVR 287
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 33.5 bits (75), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 36/190 (18%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSP---DSNMDRR 299
V LH + H +L+ N+ I+ + +KV G A E +NS P S M
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 300 ---------QMMI-------AFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGI---- 339
++M+ A D+ G ++A++ LR + P + + L GI
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 340 ----DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRIS 390
D C+ RE++ + ++ F R G +LL +L P+KRI+
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP---RVNPKGIDLLQRMLVFDPAKRIT 299
Query: 391 CLDALRHPFL 400
+AL HP+L
Sbjct: 300 AKEALEHPYL 309
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 33.5 bits (75), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDR-----HIKVGILGNAADFYEDG---------PN 288
GVNYLH+ +AH +L+ EN+ + +D+ HIK+ G A + EDG P
Sbjct: 127 GVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 289 NSSPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFL 348
+P+ ++ + + DM +G + L G P
Sbjct: 184 FVAPEI-VNYEPLGLEADMWSIGVITY------------------ILLSGASPFLGDTKQ 224
Query: 349 LQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFLCGPRWRVD 408
+ N + S + + + + + LL + KR++ +ALRHP++ VD
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP----VD 280
Query: 409 PSIDMIRWGLGSSAVRITEEYIYRQ 433
M+R + ++Y+ R+
Sbjct: 281 TQQAMVRRESVVNLENFKKQYVRRR 305
>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2
Length = 329
Score = 33.5 bits (75), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 33.5 bits (75), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 19/26 (73%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P KRIS +ALRHP++
Sbjct: 294 DLLSKMLVIDPDKRISVDEALRHPYI 319
>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And
Human Ck2alpha' In Complex With A Non-hydrolysable
Atp-analogue
pdb|3U87|B Chain B, Structure Of A Chimeric Construct Of Human Ck2alpha And
Human Ck2alpha' In Complex With A Non-hydrolysable
Atp-analogue
Length = 349
Score = 33.5 bits (75), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With
Ellagic Acid
pdb|3AMY|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With
Apigenin
pdb|3AT2|A Chain A, Crystal Structure Of Ck2alpha
pdb|3AT3|A Chain A, Crystal Structure Of Ck2alpha With Pyradine Derivative
pdb|3AT4|A Chain A, Crystal Structure Of Ck2alpha With Pyradine Derivertive
pdb|3AXW|A Chain A, Crystal Structure Of Human Ck2alpha Complexed With A
Potent Inhibitor
Length = 340
Score = 33.5 bits (75), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 148 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 206
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 207 LLVDYQMYDYSLDMWSLGCMLASMIFRK 234
>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human
Protein Kinase Ck2 Catalytic Subunit
pdb|2PVR|A Chain A, Crystal Structure Of The Catalytic Subunit Of Protein
Kinase Ck2 (c- Terminal Deletion Mutant 1-335) In
Complex With Two Sulfate Ions
Length = 334
Score = 33.5 bits (75), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 200
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRK 228
>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 8.5
pdb|3Q9X|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 6.5
pdb|3Q9X|B Chain B, Crystal Structure Of Human Ck2 Alpha In Complex With
Emodin At Ph 6.5
pdb|3Q9Y|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 8.5
pdb|3Q9Z|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 6.5
pdb|3Q9Z|B Chain B, Crystal Structure Of Human Ck2 Alpha In Complex With
Quinalizarin At Ph 6.5
pdb|3QA0|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
6.5
pdb|3QA0|B Chain B, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
6.5
Length = 336
Score = 33.5 bits (75), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945
pdb|3NGA|B Chain B, Human Ck2 Catalytic Domain In Complex With Cx-4945
pdb|3U4U|A Chain A, Casein Kinase 2 In Complex With Az-Inhibitor
Length = 333
Score = 33.5 bits (75), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn
Length = 330
Score = 33.5 bits (75), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 200
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRK 228
>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme
pdb|1JWH|B Chain B, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme
pdb|3PE1|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Alpha
Subunit In Complex With The Inhibitor Cx-4945
pdb|3PE2|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 In Complex
With The Inhibitor Cx-5011
pdb|3R0T|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Alpha
Subunit In Complex With The Inhibitor Cx-5279
Length = 337
Score = 33.5 bits (75), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane
Derivative Inhibitor (Cpa)
pdb|3MB7|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane
Derivative Inhibitor (Amr)
pdb|3OWJ|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Pyridocarbazole Derivative Inhibitor
pdb|3OWK|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Benzopyridoindole Derivative Inhibitor
pdb|3OWL|A Chain A, Human Ck2 Catalytic Domain In Complex With A
Benzopyridoindole Derivative Inhibitor
Length = 331
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme
pdb|4DGL|D Chain D, Crystal Structure Of The Ck2 Tetrameric Holoenzyme
Length = 335
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|B Chain B, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|C Chain C, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
pdb|2R7I|D Chain D, Crystal Structure Of Catalytic Subunit Of Protein Kinase
Ck2
Length = 335
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With
The Catalytic Subunit Of Protein Kinase Ck2
pdb|3C13|A Chain A, Low Ph-Value Crystal Structure Of Emodin In Complex With
The Catalytic Subunit Of Protein Kinase Ck2
pdb|3FWQ|A Chain A, Inactive Conformation Of Human Protein Kinase Ck2
Catalytic Subunit
pdb|3FWQ|B Chain B, Inactive Conformation Of Human Protein Kinase Ck2
Catalytic Subunit
pdb|3RPS|A Chain A, Structure Of Human Ck2alpha In Complex With The
Atp-Competitive Inhibitor
3-(4,5,6,7-Tetrabromo-1h-Benzotriazol-1-Yl)propan-1-Ol
pdb|3RPS|B Chain B, Structure Of Human Ck2alpha In Complex With The
Atp-Competitive Inhibitor
3-(4,5,6,7-Tetrabromo-1h-Benzotriazol-1-Yl)propan-1-Ol
pdb|3U9C|A Chain A, Structure Of A C-terminal Deletion Mutant Of Human Protein
Kinase Ck2 Catalytic Subunit With The Atp-competitive
Inhibitor Resorufin
pdb|3U9C|B Chain B, Structure Of A C-terminal Deletion Mutant Of Human Protein
Kinase Ck2 Catalytic Subunit With The Atp-competitive
Inhibitor Resorufin
pdb|4FBX|A Chain A, Complex Structure Of Human Protein Kinase Ck2 Catalytic
Subunit Crystallized In The Presence Of A Bisubstrate
Inhibitor
Length = 335
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 33.5 bits (75), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 14/26 (53%), Positives = 19/26 (73%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+LLS +L P KRIS +ALRHP++
Sbjct: 296 DLLSKMLVIDPDKRISVDEALRHPYI 321
>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D-
Ribofuranosylbenzimidazole
pdb|3H30|B Chain B, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D-
Ribofuranosylbenzimidazole
Length = 334
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph
8.5
Length = 328
Score = 33.5 bits (75), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 199
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 33.1 bits (74), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 43/187 (22%), Positives = 75/187 (40%), Gaps = 40/187 (21%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDR-----HIKVGILGNAADFYEDG---------PN 288
GVNYLH+ +AH +L+ EN+ + +D+ HIK+ G A + EDG P
Sbjct: 127 GVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPE 183
Query: 289 NSSPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDPSCLREFL 348
+P+ ++ + + DM +G + L G P
Sbjct: 184 FVAPEI-VNYEPLGLEADMWSIGVITY------------------ILLSGASPFLGDTKQ 224
Query: 349 LQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFLCGPRWRVD 408
+ N + S + + + + + LL + KR++ +ALRHP++ VD
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP----VD 280
Query: 409 PSIDMIR 415
M+R
Sbjct: 281 NQQAMVR 287
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 33.1 bits (74), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 45/190 (23%), Positives = 76/190 (40%), Gaps = 36/190 (18%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMD----- 297
V LH + H +L+ N+ I+ + +KV G A E +NS P
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 298 -------RRQMMI-------AFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGI---- 339
++M+ A D+ G ++A++ LR + P + + L GI
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 340 ----DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRIS 390
D C+ RE++ + ++ F R G +LL +L P+KRI+
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP---RVNPKGIDLLQRMLVFDPAKRIT 299
Query: 391 CLDALRHPFL 400
+AL HP+L
Sbjct: 300 AKEALEHPYL 309
>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase
Ck2alpha With Altered Cosubstrate Specificity
pdb|3JUH|B Chain B, Crystal Structure Of A Mutant Of Human Protein Kinase
Ck2alpha With Altered Cosubstrate Specificity
Length = 335
Score = 33.1 bits (74), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 42/88 (47%), Gaps = 10/88 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I R +++ G A+FY G + P+
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWG-LAEFYHPGQEYNVRVASRYFKGPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRE 321
+D + + DM +G M+A M+ R+
Sbjct: 202 LLVDYQMYDYSLDMWSLGCMLASMIFRK 229
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 32.7 bits (73), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 12/27 (44%), Positives = 20/27 (74%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFLC 401
NL++ +L P+KRI+ AL+HP++C
Sbjct: 266 NLINQMLTINPAKRITADQALKHPWVC 292
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 32.7 bits (73), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 250
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 307
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 308 LAHPYL---EQYYDPSDEPI 324
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 32.7 bits (73), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 252
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 253 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 309
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 310 LAHPYL---EQYYDPSDEPI 326
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 32.7 bits (73), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 270
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 271 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 327
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 328 LAHPYL---EQYYDPSDEPI 344
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 32.7 bits (73), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 31/196 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPV-DRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ ++ D I L AD D +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDP-------------LIFTKFKSFLTKG 338
P+ ++ + + D+ VG ++A+M+ + P ++ + + L G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 339 IDPSCLREFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHP 398
I+ R +LL + ++N N F D +LL +L P KRI AL HP
Sbjct: 258 INLKA-RNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQALAHP 313
Query: 399 FLCGPRWRVDPSIDMI 414
+L DPS + I
Sbjct: 314 YLAQ---YYDPSDEPI 326
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 32.7 bits (73), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 32.7 bits (73), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 248
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 249 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 305
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 306 LAHPYL---EQYYDPSDEPI 322
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 32.7 bits (73), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 255
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 256 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 312
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 313 LAHPYL---EQYYDPSDEPI 329
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 32.7 bits (73), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 256
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 257 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 313
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 314 LAHPYL---EQYYDPSDEPI 330
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 32.7 bits (73), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 247
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 248 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 304
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 305 LAHPYL---EQYYDPSDEPI 321
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 32.7 bits (73), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 254
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 311
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 312 LAHPYL---EQYYDPSDEPI 328
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 32.7 bits (73), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPV-DRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ ++ D I L AD D +
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 270
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 271 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 327
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 328 LAHPYL---EQYYDPSDEPI 344
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 32.7 bits (73), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 254
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 311
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 312 LAHPYL---EQYYDPSDEPI 328
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 32.7 bits (73), Expect = 0.75, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 255
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 256 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 312
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 313 LAHPYL---EQYYDPSDEPI 329
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 32.7 bits (73), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 252
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 253 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 309
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 310 LAHPYLAQ---YYDPSDEPI 326
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 32.7 bits (73), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 141 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 200
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQPIFP 228
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 32.7 bits (73), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 11/27 (40%), Positives = 21/27 (77%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFLC 401
+L++ +L P+KRI+ +AL+HP++C
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWIC 265
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 32.7 bits (73), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 32.3 bits (72), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 138 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 197
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQPIFP 225
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 32.3 bits (72), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 254
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 311
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 312 LAHPYL---EQYYDPSDEPI 328
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 32.3 bits (72), Expect = 0.77, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 32.3 bits (72), Expect = 0.78, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 254
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 311
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 312 LAHPYL---EQYYDPSDEPI 328
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 32.3 bits (72), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 32.3 bits (72), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPEQE 248
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 249 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 305
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 306 LAHPYL---EQYYDPSDEPI 322
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 32.3 bits (72), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFP 236
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 32.3 bits (72), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 258
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 259 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 315
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 316 LAHPYL---EQYYDPSDEPI 332
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 32.3 bits (72), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHI-SPVDRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ + + D I L AD D +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 250
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 307
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 308 LAHPYL---EQYYDPSDEPI 324
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 32.3 bits (72), Expect = 0.81, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPV-DRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ ++ D I L AD D +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 254
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 311
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 312 LAHPYL---EQYYDPSDEPI 328
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 32.3 bits (72), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 145 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 204
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQPIFP 232
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 32.3 bits (72), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 13/36 (36%), Positives = 24/36 (66%), Gaps = 1/36 (2%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRHIKVGILG 277
+G+ +LHS G+ + +L+L+N+ + D HIK+ G
Sbjct: 130 LGLQFLHSKGIVYRDLKLDNILLDK-DGHIKIADFG 164
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 32.3 bits (72), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPV-DRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ ++ D I L AD D +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 250
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 251 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 307
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 308 LAHPYL---EQYYDPSDEPI 324
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 32.3 bits (72), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFP 236
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 32.3 bits (72), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 11/27 (40%), Positives = 21/27 (77%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFLC 401
+L++ +L P+KRI+ +AL+HP++C
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWIC 265
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 32.3 bits (72), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 156 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 215
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQPIFP 243
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 32.3 bits (72), Expect = 0.85, Method: Compositional matrix adjust.
Identities = 49/200 (24%), Positives = 81/200 (40%), Gaps = 39/200 (19%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPV-DRHIKVGILGNAADFYEDGPN----------NSS 291
G+ Y+HS + H +L+ N+ ++ D I L AD D +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTK-----GI------- 339
P+ ++ + + D+ VG ++A+M+ + P K +L + GI
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP-----GKHYLDQLNHILGILGSPSQE 254
Query: 340 DPSCL-----REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDA 394
D +C+ R +LL + ++N N F D +LL +L P KRI A
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQA 311
Query: 395 LRHPFLCGPRWRVDPSIDMI 414
L HP+L DPS + I
Sbjct: 312 LAHPYL---EQYYDPSDEPI 328
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 32.3 bits (72), Expect = 0.86, Method: Compositional matrix adjust.
Identities = 13/36 (36%), Positives = 24/36 (66%), Gaps = 1/36 (2%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRHIKVGILG 277
+G+ +LHS G+ + +L+L+N+ + D HIK+ G
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDK-DGHIKIADFG 163
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 32.3 bits (72), Expect = 0.86, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 230
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFP 258
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 32.3 bits (72), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 32.3 bits (72), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 32.0 bits (71), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 175 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 234
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQPIFP 262
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 32.0 bits (71), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFP 224
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 32.0 bits (71), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 41/180 (22%), Positives = 74/180 (41%), Gaps = 24/180 (13%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS--------SPD 293
IG +L S + H +++ NV ++ D +K+ G+A PN + +P+
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPE 201
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLRELMDPLIFTKFKSFLTKGIDP--SCLREFLLQV 351
+ A D+ VG + A+M+L E P+ + I C +L+
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE---PIFRGDNSAGQLHEIVRVLGCPSREVLRK 258
Query: 352 LNRN-------SSSGNTGFQILD----RNWGAGWNLLSLLLATKPSKRISCLDALRHPFL 400
LN + +S G + ++ ++LLS LL P +R+ +AL HP+
Sbjct: 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 32.0 bits (71), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 142 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 201
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 202 ATDYTSSIDVWSAGCVLAELLLGQPIFP 229
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 32.0 bits (71), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 165 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 224
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 225 ATDYTSSIDVWSAGCVLAELLLGQPIFP 252
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 32.0 bits (71), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 173 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 232
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 233 ATDYTSSIDVWSAGCVLAELLLGQPIFP 260
>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase
In Yeast
pdb|2JD5|A Chain A, Sky1p Bound To Npl3p-Derived Substrate Peptide
pdb|2JD5|B Chain B, Sky1p Bound To Npl3p-Derived Substrate Peptide
Length = 373
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 20/55 (36%), Positives = 33/55 (60%), Gaps = 7/55 (12%)
Query: 242 IGVNYLHSH-GLAHTELRLENVHISPVDR-----HIKVGILGNAADFYEDGPNNS 290
+G++Y+H G+ HT+++ ENV + VD IK+ LGNA +Y++ NS
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDEHYTNS 195
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 216 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 275
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 276 ATDYTSSIDVWSAGCVLAELLLGQPIFP 303
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFP 258
>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From
Mycobacterium Tuberculosis In Complex With
Tetrahydrobenzothiophene Ax20017
pdb|2PZI|B Chain B, Crystal Structure Of Protein Kinase Pkng From
Mycobacterium Tuberculosis In Complex With
Tetrahydrobenzothiophene Ax20017
Length = 681
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 29/124 (23%), Positives = 55/124 (44%), Gaps = 23/124 (18%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILG-----NAADFYEDGPNNSSPDSNMD 297
++YLHS GL + +L+ EN+ ++ + +K+ LG N+ + P +P+ +
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPGFQAPE--IV 249
Query: 298 RRQMMIAFDMRCVGFMMAKMVLR------------ELMDPLI--FTKFKSFLTKGIDPSC 343
R +A D+ VG +A + L DP++ + + L + IDP
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDP 309
Query: 344 LREF 347
+ F
Sbjct: 310 RQRF 313
>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With
Bound Adp
pdb|1Q8Y|B Chain B, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With
Bound Adp
pdb|1Q8Z|A Chain A, The Apoenzyme Structure Of The Yeast Sr Protein Kinase,
Sky1p
pdb|1Q8Z|B Chain B, The Apoenzyme Structure Of The Yeast Sr Protein Kinase,
Sky1p
pdb|1Q97|A Chain A, The Structure Of The Saccharomyces Cerevisiae Sr Protein
Kinase, Sky1p, With Bound Atp
pdb|1Q97|B Chain B, The Structure Of The Saccharomyces Cerevisiae Sr Protein
Kinase, Sky1p, With Bound Atp
pdb|1Q99|A Chain A, Crystal Structure Of The Saccharomyces Cerevisiae Sr
Protein Kinsae, Sky1p, Complexed With The
Non-Hydrolyzable Atp Analogue, Amp-Pnp
pdb|1Q99|B Chain B, Crystal Structure Of The Saccharomyces Cerevisiae Sr
Protein Kinsae, Sky1p, Complexed With The
Non-Hydrolyzable Atp Analogue, Amp-Pnp
Length = 373
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 20/55 (36%), Positives = 33/55 (60%), Gaps = 7/55 (12%)
Query: 242 IGVNYLHSH-GLAHTELRLENVHISPVDR-----HIKVGILGNAADFYEDGPNNS 290
+G++Y+H G+ HT+++ ENV + VD IK+ LGNA +Y++ NS
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC-WYDEHYTNS 195
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 32.0 bits (71), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 246 YLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSSPDSNMDRRQMMI-- 303
Y+HS G+ H +++ +N+ + P +K+ G+A PN S S R +I
Sbjct: 150 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 209
Query: 304 ------AFDMRCVGFMMAKMVLRELMDP 325
+ D+ G ++A+++L + + P
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQPIFP 237
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 31.6 bits (70), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 15/49 (30%), Positives = 24/49 (48%), Gaps = 1/49 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNSS 291
GV+Y+HS L H +L+ N+ + + +K+G G DG S
Sbjct: 148 GVDYIHSKKLIHRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRS 195
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 31.2 bits (69), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 23/70 (32%), Positives = 31/70 (44%), Gaps = 6/70 (8%)
Query: 345 REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFLCGPR 404
R +LL + ++N N F D +LL +L P KRI AL HP+L
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQALAHPYL---E 314
Query: 405 WRVDPSIDMI 414
DPS + I
Sbjct: 315 QYYDPSDEPI 324
>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform
Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo
Sapiens
Length = 350
Score = 31.2 bits (69), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 21/87 (24%), Positives = 40/87 (45%), Gaps = 10/87 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I + +++ G A+FY + P+
Sbjct: 144 ALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWG-LAEFYHPAQEYNVRVASRYFKGPE 202
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLR 320
+D + + DM +G M+A M+ R
Sbjct: 203 LLVDYQMYDYSLDMWSLGCMLASMIFR 229
>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein
Kinase Ck2alpha Prime With A Potent Indazole-Derivative
Inhibitor
Length = 339
Score = 31.2 bits (69), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 21/87 (24%), Positives = 40/87 (45%), Gaps = 10/87 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS---------SPD 293
++Y HS G+ H +++ NV I + +++ G A+FY + P+
Sbjct: 149 ALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWG-LAEFYHPAQEYNVRVASRYFKGPE 207
Query: 294 SNMDRRQMMIAFDMRCVGFMMAKMVLR 320
+D + + DM +G M+A M+ R
Sbjct: 208 LLVDYQMYDYSLDMWSLGCMLASMIFR 234
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 31.2 bits (69), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 23/70 (32%), Positives = 31/70 (44%), Gaps = 6/70 (8%)
Query: 345 REFLLQVLNRNSSSGNTGFQILDRNWGAGWNLLSLLLATKPSKRISCLDALRHPFLCGPR 404
R +LL + ++N N F D +LL +L P KRI AL HP+L
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNAD---SKALDLLDKMLTFNPHKRIEVEQALAHPYL---E 314
Query: 405 WRVDPSIDMI 414
DPS + I
Sbjct: 315 QYYDPSDEPI 324
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 31.2 bits (69), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 26/45 (57%), Gaps = 1/45 (2%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
IG+ +LH G+ + +L+L+NV + + HIK+ G + DG
Sbjct: 131 IGLFFLHKRGIIYRDLKLDNVMLDS-EGHIKIADFGMCKEHMMDG 174
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 31.2 bits (69), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/34 (44%), Positives = 20/34 (58%)
Query: 373 GWNLLSLLLATKPSKRISCLDALRHPFLCGPRWR 406
G NLL +L P+KRI+ AL HP+L R +
Sbjct: 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 30.8 bits (68), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
GV YLH++ + H +L+L N+ ++ D +K+G G A DG
Sbjct: 138 GVQYLHNNRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDG 180
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 30.8 bits (68), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
GV YLH++ + H +L+L N+ ++ D +K+G G A DG
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDG 196
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 30.8 bits (68), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
GV YLH++ + H +L+L N+ ++ D +K+G G A DG
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDG 196
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 30.8 bits (68), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 26/44 (59%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
GV YLH++ + H +L+L N+ ++ D +K+G G A DG
Sbjct: 154 GVQYLHNNRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDG 196
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 30.8 bits (68), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 9/34 (26%), Positives = 20/34 (58%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGIL 276
G+ Y+H H + H +L+ EN+ + ++ + I+
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 30.4 bits (67), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 11/83 (13%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA--ADFYEDGPNNSSPDSNMDRR 299
+GV Y+HS G+ H +L+ N ++ D +KV G A D+ E+G N+ P S +
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQ-DCSVKVCDFGLARTVDYPENG-NSQLPISPRED- 223
Query: 300 QMMIAFDMRCVGFMMAKMVLREL 322
DM V F K + R+L
Sbjct: 224 ------DMNLVTFPHTKNLKRQL 240
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 30.4 bits (67), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 23/74 (31%), Positives = 34/74 (45%), Gaps = 5/74 (6%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFLCGPRWRVDPSIDMIRWGLGSSAVRITEEYI---Y 431
+ + LL +P KR++ DAL HP+L G + I R+ +I E+Y
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRY--NKIRQKIKEKYADWPA 340
Query: 432 RQPQRARLAYFVEL 445
QP R+A F L
Sbjct: 341 PQPAIGRIANFSSL 354
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 30.4 bits (67), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 14/89 (15%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS-----------S 291
G+ YLH H + H +L+ N+ + + +K+ G A F PN + +
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRA 180
Query: 292 PDSNMDRRQMMIAFDMRCVGFMMAKMVLR 320
P+ R + DM VG ++A+++LR
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLR 209
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 30.4 bits (67), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 11/26 (42%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+L++ +L PSKRI+ +AL+HP++
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWI 271
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 30.4 bits (67), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 21/179 (11%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRH----IKVGILGNAADFYEDGPNNS-------- 290
GVN+ HS H +L+ +N+ +S D +K+G G A F +
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203
Query: 291 -SPDSNMDRRQMMIAFDMRCVGFMMAKMVLRELM---DPLIFTKFKSFLTKGIDPSCLRE 346
P+ + R + D+ + + A+M+++ + D I FK F G+
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263
Query: 347 FLLQVLNRNSSSGNTGFQILDRNWGAGWNLL-----SLLLATKPSKRISCLDALRHPFL 400
+ + + S + L R GA + + +L P KRIS +AL HP+
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 30.4 bits (67), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 155
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 30.4 bits (67), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 122 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 157
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 30.0 bits (66), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 119 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 154
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 30.0 bits (66), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 121 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 156
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 30.0 bits (66), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 11/26 (42%), Positives = 20/26 (76%)
Query: 375 NLLSLLLATKPSKRISCLDALRHPFL 400
+L++ +L PSKRI+ +AL+HP++
Sbjct: 257 DLINKMLTINPSKRITAAEALKHPWI 282
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 30.0 bits (66), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 9/34 (26%), Positives = 20/34 (58%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGIL 276
G+ Y+H H + H +L+ EN+ + ++ + I+
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 30.0 bits (66), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 9/34 (26%), Positives = 20/34 (58%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGIL 276
G+ Y+H H + H +L+ EN+ + ++ + I+
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 30.0 bits (66), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 149 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 184
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 30.0 bits (66), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 141 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 176
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 30.0 bits (66), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 177
>pdb|1SH0|A Chain A, Crystal Structure Of Norwalk Virus Polymerase (Triclinic)
pdb|1SH0|B Chain B, Crystal Structure Of Norwalk Virus Polymerase (Triclinic)
pdb|1SH2|A Chain A, Crystal Structure Of Norwalk Virus Polymerase (metal-free,
Centered Orthorhombic)
pdb|1SH3|A Chain A, Crystal Structure Of Norwalk Virus Polymerase (Mgso4
Crystal Form)
pdb|1SH3|B Chain B, Crystal Structure Of Norwalk Virus Polymerase (Mgso4
Crystal Form)
Length = 510
Score = 30.0 bits (66), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 3/118 (2%)
Query: 494 LTVTRPSKSNTNLSFTSDISFTVMTGREWPHDKTGITGKLQINSLFRLMAGRRLYIKEEK 553
L TRP K+ L + D++ R D G GKL+ +S+ R M R E+
Sbjct: 367 LKPTRPDKTEGPLVISEDLNGLTFLRRTVTRDPAGWFGKLEQSSILRQMYWTRGPNHEDP 426
Query: 554 TTPGLFSSQSDAQNSLVQKLSGRKWRKAVPFKDIPSSLSVAKLVSGDIELTMSLGHPL 611
+ + SQ Q + L G F S L +A+L G ++ + P+
Sbjct: 427 SETMIPHSQRPIQ---LMSLLGEAALHGPAFYSKISKLVIAELKEGGMDFYVPRQEPM 481
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 30.0 bits (66), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 141 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 176
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 177
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 177
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 15/42 (35%), Positives = 24/42 (57%), Gaps = 2/42 (4%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNAADF 282
GV YLH H + H +L+ EN+ + ++ IK+ G +A F
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 179
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 126 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 161
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 14/35 (40%), Positives = 21/35 (60%), Gaps = 1/35 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILG 277
V +LHS GL H +L+ N+ + +D +KVG G
Sbjct: 176 AVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFG 209
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 179
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 145 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 180
>pdb|2OQR|A Chain A, The Structure Of The Response Regulator Regx3 From
Mycobacterium Tuberculosis
Length = 230
Score = 30.0 bits (66), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 16/32 (50%), Positives = 21/32 (65%), Gaps = 1/32 (3%)
Query: 344 LREF-LLQVLNRNSSSGNTGFQILDRNWGAGW 374
L+EF LL+ L RNS T Q++DR WGA +
Sbjct: 159 LKEFDLLEYLMRNSGRVLTRGQLIDRVWGADY 190
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 30.0 bits (66), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 177
>pdb|3BSN|A Chain A, Norwalk Virus Polymerase Bound To 5-Nitrocytidine
Triphosphate And Primer-Template Rna
pdb|3BSO|A Chain A, Norwalk Virus Polymerase Bound To Cytidine 5'-Triphosphate
And Primer- Template Rna
pdb|3H5X|A Chain A, Crystal Structure Of
2'-Amino-2'-Deoxy-Cytidine-5'-Triphosphate Bound To
Norovirus Gii Rna Polymerase
pdb|3H5Y|A Chain A, Norovirus Polymerase+primerTEMPLATE+CTP COMPLEX AT 6 MM
MNCL2
Length = 510
Score = 30.0 bits (66), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 3/118 (2%)
Query: 494 LTVTRPSKSNTNLSFTSDISFTVMTGREWPHDKTGITGKLQINSLFRLMAGRRLYIKEEK 553
L TRP K+ L + D++ R D G GKL+ +S+ R M R E+
Sbjct: 367 LKPTRPDKTEGPLVISEDLNGLTFLRRTVTRDPAGWFGKLEQSSILRQMYWTRGPNHEDP 426
Query: 554 TTPGLFSSQSDAQNSLVQKLSGRKWRKAVPFKDIPSSLSVAKLVSGDIELTMSLGHPL 611
+ + SQ Q + L G F S L +A+L G ++ + P+
Sbjct: 427 SETMIPHSQRPIQ---LMSLLGEAALHGPAFYSKISKLVIAELKEGGMDFYVPRQEPM 481
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 30.0 bits (66), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 145 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 180
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 30.0 bits (66), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 179
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 30.0 bits (66), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 147 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 182
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 30.0 bits (66), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 179
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 30.0 bits (66), Expect = 4.7, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 179
>pdb|2B43|A Chain A, Crystal Structure Of The Norwalk Virus Rna Dependent Rna
Polymerase From Strain HuNLVDRESDEN1741997GE
pdb|2B43|B Chain B, Crystal Structure Of The Norwalk Virus Rna Dependent Rna
Polymerase From Strain HuNLVDRESDEN1741997GE
pdb|2B43|C Chain C, Crystal Structure Of The Norwalk Virus Rna Dependent Rna
Polymerase From Strain HuNLVDRESDEN1741997GE
pdb|2B43|D Chain D, Crystal Structure Of The Norwalk Virus Rna Dependent Rna
Polymerase From Strain HuNLVDRESDEN1741997GE
Length = 526
Score = 30.0 bits (66), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 3/118 (2%)
Query: 494 LTVTRPSKSNTNLSFTSDISFTVMTGREWPHDKTGITGKLQINSLFRLMAGRRLYIKEEK 553
L TRP K+ L + D++ R D G GKL+ +S+ R M R E+
Sbjct: 368 LKPTRPDKTEGPLVISEDLNGLTFLRRTVTRDPAGWFGKLEQSSILRQMYWTRGPNHEDP 427
Query: 554 TTPGLFSSQSDAQNSLVQKLSGRKWRKAVPFKDIPSSLSVAKLVSGDIELTMSLGHPL 611
+ + SQ Q + L G F S L +A+L G ++ + P+
Sbjct: 428 SETMIPHSQRPIQ---LMSLLGEAALHGPAFYSKISKLVIAELKEGGMDFYVPRQEPM 482
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 30.0 bits (66), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 14/35 (40%), Positives = 21/35 (60%), Gaps = 1/35 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILG 277
V +LHS GL H +L+ N+ + +D +KVG G
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFT-MDDVVKVGDFG 163
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 30.0 bits (66), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 13/37 (35%), Positives = 22/37 (59%), Gaps = 1/37 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNA 279
+ YLH G+ H +L+ EN+ ++ D HI++ G A
Sbjct: 144 ALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTA 179
>pdb|3HLE|A Chain A, Simvastatin Synthase (Lovd), From Aspergillus Terreus, S5
Mutant, S76a Mutant, Complex With Monacolin J Acid
pdb|3HLF|A Chain A, Simvastatin Synthase (Lovd), From Aspergillus Terreus, S5
Mutant, S76a Mutant, Complex With Simvastatin
pdb|3HLG|A Chain A, Simvastatin Synthase (lovd), From Aspergillus Terreus, S5
Mutant, S76a Mutant, Complex With Lovastatin
Length = 432
Score = 29.6 bits (65), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 19/77 (24%), Positives = 37/77 (48%), Gaps = 10/77 (12%)
Query: 578 WRKAVPFKDIPSSLSVAKLVSGDIELTMSLGHPLNHNVDAAKNIVQEVRTQIPPEMFDL- 636
+RKAV + IP ++ +A+ SG++ T G A+ + ++ Q+PP D
Sbjct: 40 FRKAVESRQIPGAVIMARDASGNLNYTRCFG---------ARTVRRDENNQLPPLQVDTP 90
Query: 637 SKFVCGTYVDSRFLVLR 653
+ T + + +VL+
Sbjct: 91 CRLAAATKLLTTIMVLQ 107
>pdb|3HL9|A Chain A, Simvastatin Synthase (Lovd) From Aspergillus Terreus,
Unliganded
pdb|3HL9|B Chain B, Simvastatin Synthase (Lovd) From Aspergillus Terreus,
Unliganded
pdb|3HL9|C Chain C, Simvastatin Synthase (Lovd) From Aspergillus Terreus,
Unliganded
pdb|3HL9|D Chain D, Simvastatin Synthase (Lovd) From Aspergillus Terreus,
Unliganded
pdb|3HLB|A Chain A, Simvastatin Synthase (Lovd) From Aspergillus Terreus,
Unliganded, Selenomethionyl Derivative
pdb|3HLB|B Chain B, Simvastatin Synthase (Lovd) From Aspergillus Terreus,
Unliganded, Selenomethionyl Derivative
pdb|3HLB|C Chain C, Simvastatin Synthase (Lovd) From Aspergillus Terreus,
Unliganded, Selenomethionyl Derivative
pdb|3HLB|D Chain D, Simvastatin Synthase (Lovd) From Aspergillus Terreus,
Unliganded, Selenomethionyl Derivative
Length = 432
Score = 29.3 bits (64), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 9/58 (15%)
Query: 578 WRKAVPFKDIPSSLSVAKLVSGDIELTMSLGHPLNHNVDAAKNIVQEVRTQIPPEMFD 635
+RKAV + IP ++ +A+ SG++ T G A+ + ++ Q+PP D
Sbjct: 40 FRKAVKSRQIPGAVIMARDASGNLNYTRCFG---------ARTVRRDENNQLPPLQVD 88
>pdb|3HLC|A Chain A, Simvastatin Synthase (Lovd) From Aspergillus Terreus, S5
Mutant, Unliganded
pdb|3HLD|A Chain A, Simvastatin Synthase (Lovd), From Aspergillus Terreus, S5
Mutant Complex With Monacolin J Acid
Length = 432
Score = 29.3 bits (64), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 19/77 (24%), Positives = 37/77 (48%), Gaps = 10/77 (12%)
Query: 578 WRKAVPFKDIPSSLSVAKLVSGDIELTMSLGHPLNHNVDAAKNIVQEVRTQIPPEMFDL- 636
+RKAV + IP ++ +A+ SG++ T G A+ + ++ Q+PP D
Sbjct: 40 FRKAVESRQIPGAVIMARDASGNLNYTRCFG---------ARTVRRDENNQLPPLQVDTP 90
Query: 637 SKFVCGTYVDSRFLVLR 653
+ T + + +VL+
Sbjct: 91 CRLASATKLLTTIMVLQ 107
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 29.3 bits (64), Expect = 7.4, Method: Compositional matrix adjust.
Identities = 14/40 (35%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNA 279
+ V YLH +G+ H +L+ ENV +S + IK+ G++
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 29.3 bits (64), Expect = 7.5, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 23/44 (52%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
G+ YLHS + H +++ +NV +S H + G+A DG
Sbjct: 197 GLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 240
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 29.3 bits (64), Expect = 7.5, Method: Compositional matrix adjust.
Identities = 14/40 (35%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNA 279
+ V YLH +G+ H +L+ ENV +S + IK+ G++
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 29.3 bits (64), Expect = 7.5, Method: Compositional matrix adjust.
Identities = 14/40 (35%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNA 279
+ V YLH +G+ H +L+ ENV +S + IK+ G++
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 29.3 bits (64), Expect = 7.6, Method: Compositional matrix adjust.
Identities = 14/40 (35%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNA 279
+ V YLH +G+ H +L+ ENV +S + IK+ G++
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 29.3 bits (64), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 23/44 (52%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
G+ YLHS + H +++ +NV +S H + G+A DG
Sbjct: 178 GLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 221
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 29.3 bits (64), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 14/40 (35%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNA 279
+ V YLH +G+ H +L+ ENV +S + IK+ G++
Sbjct: 264 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 303
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 29.3 bits (64), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 14/40 (35%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNA 279
+ V YLH +G+ H +L+ ENV +S + IK+ G++
Sbjct: 124 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 163
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 28.9 bits (63), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
+ YLHS + + +++LEN+ + D HIK+ G + DG
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 159
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 28.9 bits (63), Expect = 8.7, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
+ YLHS + + +++LEN+ + D HIK+ G + DG
Sbjct: 120 ALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 162
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 28.9 bits (63), Expect = 8.8, Method: Compositional matrix adjust.
Identities = 14/40 (35%), Positives = 24/40 (60%), Gaps = 2/40 (5%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRH--IKVGILGNA 279
+ V YLH +G+ H +L+ ENV +S + IK+ G++
Sbjct: 131 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 170
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 28.9 bits (63), Expect = 8.9, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
+ YLHS + + +++LEN+ + D HIK+ G + DG
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 159
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 28.9 bits (63), Expect = 9.1, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
+ YLHS + + +++LEN+ + D HIK+ G + DG
Sbjct: 122 ALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 164
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 28.9 bits (63), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
+ YLHS + + +++LEN+ + D HIK+ G + DG
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 159
>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum
In Complex With Indirubin E804
pdb|3EB0|C Chain C, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum
In Complex With Indirubin E804
Length = 383
Score = 28.9 bits (63), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 34/184 (18%), Positives = 74/184 (40%), Gaps = 37/184 (20%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDGPNNS--------SPDS 294
V ++HS G+ H +++ +N+ ++ D +K+ G+A P+ + +P+
Sbjct: 153 AVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPEL 212
Query: 295 NMDRRQMMIAFDMRCVGFMMAKMVLRELM-------DPLI-FTKFKSFLTKGIDPSCLRE 346
+ + + D+ +G + +++L + + D L+ + TK
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKE-------- 264
Query: 347 FLLQVLNRNSSSGNTGFQILD-RNW---------GAGWNLLSLLLATKPSKRISCLDALR 396
Q++ N F L ++W +LL +L +P RI+ +A+
Sbjct: 265 ---QMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321
Query: 397 HPFL 400
HPF
Sbjct: 322 HPFF 325
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 28.9 bits (63), Expect = 9.4, Method: Compositional matrix adjust.
Identities = 13/36 (36%), Positives = 23/36 (63%), Gaps = 1/36 (2%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRHIKVGILG 277
+ +NYLH G+ + +L+L+NV + + HIK+ G
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDS-EGHIKLTDYG 166
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 28.9 bits (63), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
+ YLHS + + +++LEN+ + D HIK+ G + DG
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 159
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 28.9 bits (63), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 26/45 (57%), Gaps = 1/45 (2%)
Query: 242 IGVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
IG+ +L S G+ + +L+L+NV + + HIK+ G + DG
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDG 496
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 28.9 bits (63), Expect = 9.7, Method: Compositional matrix adjust.
Identities = 14/44 (31%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVGILGNAADFYEDG 286
+ YLHS + + +++LEN+ + D HIK+ G + DG
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG 159
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 28.9 bits (63), Expect = 9.9, Method: Compositional matrix adjust.
Identities = 32/147 (21%), Positives = 61/147 (41%), Gaps = 24/147 (16%)
Query: 243 GVNYLHSHGLAHTELRLENVHISPVDRHIKVG--------ILGNAADFYEDGPNNSSPDS 294
V Y H + H +L+ EN+ + D +IK+ GN D + P ++P+
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPEL 183
Query: 295 NMDRRQMMIAFDMRCVGFMMAKMV----------LRELMDPLIFTKFKSFLTKGID-PSC 343
++ D+ +G ++ +V L+EL + ++ K++ D +
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 243
Query: 344 LREFLLQVLNRNSSSGNTGFQILDRNW 370
L++FL+ N S T QI+ W
Sbjct: 244 LKKFLI----LNPSKRGTLEQIMKDRW 266
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.136 0.417
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 18,206,302
Number of Sequences: 62578
Number of extensions: 691736
Number of successful extensions: 2062
Number of sequences better than 100.0: 222
Number of HSP's better than 100.0 without gapping: 114
Number of HSP's successfully gapped in prelim test: 108
Number of HSP's that attempted gapping in prelim test: 1914
Number of HSP's gapped (non-prelim): 250
length of query: 667
length of database: 14,973,337
effective HSP length: 105
effective length of query: 562
effective length of database: 8,402,647
effective search space: 4722287614
effective search space used: 4722287614
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 55 (25.8 bits)